Cosmos Pharm reports 5.20 percent sales growth for Cosmos Pharm stock
Published on 10/20/2026 at 04:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly growth and valuation
- Cosmos Pharm reported JPY 286.653 billion in first-quarter sales on October 13, 2026.
- Net income increased 1.00 percent to JPY 8.251 billion for the period ended August 31, 2026.
- The company operated 1,717 stores at the end of August 2026.
Cosmos Pharm (ISIN JP3298400007) reported first-quarter revenue of JPY 286.653 billion, up 5.20 percent from JPY 272.394 billion a year earlier. The results were published on October 13, 2026, by Cosmos Pharmaceutical.
First-quarter growth stays measured
According to RTTNews, net income for the quarter ended August 31, 2026, rose 1.00 percent to JPY 8.251 billion from JPY 8.171 billion. Basic earnings per share increased to JPY 104.11 from JPY 103.10, also a 1.00 percent gain.
The comparison shows a clear difference between sales and profit growth. Revenue advanced 5.20 percent, while net income and earnings per share each increased 1.00 percent, leaving operating efficiency central to the next results cycle.
What does the margin signal?
Operating profit reached JPY 12.005 billion in the first quarter, up 3.10 percent, while recurring profit rose 4.70 percent to JPY 12.766 billion. The operating margin was 4.20 percent, according to Shoninsha.
Store expansion added 13 locations during the period, although four stores closed. The company had 1,717 stores at the end of August 2026, with general food generating JPY 180.505 billion, or 63.00 percent of quarterly sales.
Three dated milestones
On July 13, 2026, the company forecast fiscal-year revenue of JPY 1.190 trillion and recurring profit of JPY 45.700 billion, as reported by Kabutan. On October 13, 2026, it reported first-quarter revenue of JPY 286.653 billion. On October 19, 2026, the stock was quoted at JPY 6,459.00 on the Japan Exchange, according to Marketscreener.
Tokyo valuation context
TradingView identifies Cosmos Pharmaceutical Corporation as a Tokyo Stock Exchange company with ticker 3349 and ISIN JP3298400007. Its business covers pharmaceutical, cosmetic, daily-necessity and food retail in Japan, giving the sales mix a strong everyday-consumption component.
For investors, the key issue is the gap between 5.20 percent revenue growth and 1.00 percent net-income growth. The first-quarter figures support continued expansion, while the smaller profit increase keeps cost discipline relevant.
Stock and company facts
Cosmos Pharm was last quoted at JPY 6,459.00 on the Japan Exchange on October 19, 2026. The company had 1,717 stores at the end of August 2026, and first-quarter revenue was JPY 286.653 billion.
Cosmos Pharm at a glance
- Company: COSMOS Pharmaceutical Corporation
- ISIN: JP3298400007
- Ticker: 3349
- Primary exchange: Tokyo Stock Exchange
- Sector / Industry: Consumer staples / drugstore retail
- First-quarter revenue: JPY 286.653 billion for the period ended August 31, 2026
- First-quarter net income: JPY 8.251 billion for the period ended August 31, 2026
Market context: Market report Nikkei 225.
